Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy – Endocrinology Advisor

Reports of immune checkpoint inhibitors causing immune-related adverse events such as insulin-dependent diabetes are on the rise, according to a case series published in Diabetes Care.

Source: Increasing Incidence of Diabetes After Immune Checkpoint Inhibitor Therapy – Endocrinology Advisor